Investor Relations


The following information is disclosed in accordance with Rule 26 of the AIM Rules (February 2007):

Description of the business

Please click on the link below for a description of the business.
Link Last updated:
Description of the business 29th June 2010
The names of the directors and biographical details

Please click on the link below for the names of the directors and brief biographical details of each.
Link Last updated:
The names of the directors and biographical details 29th June 2010
Directors' responsibilities

Please click on the link below for a description of Directors' responsibilities.
Link Last updated:
Directors' responsibilities 29th June 2010
Board committees

Please click on the link below for information on the Audit and Remuneration Committees together with the membership of those committees.
Link Last updated:
Audit Committee 29th June 2010
Remuneration Committee
Country of incorporation and main country of operation:

Alliance Pharma plc is incorporated in England (Registration Number 04241478). Its main country of operation is the United Kingdom.
  Last updated:
  29th June 2010
Current constitutional documents

Please click on the link below for the Memorandum and the Articles of Association.
Link Last updated:
Memorandum of Association 29th June 2010
Amended Articles of Association
Details of exchanges and trading platforms

The Company’s ordinary shares are listed on AIM (EPIC code: APH) and not on any other exchanges or trading platforms.

The Company’s Convertible Unsecured Subordinated Loan Stock 2013 are also traded on AIM (EPIC code: APHA).
  Last updated:
  29th June 2010
Number of securities in issue

The number of ordinary shares in issue is 232,519,622. The Company does not hold any ordinary shares in Treasury. Insofar as the Company is aware, the percentage of securities that is not in public hands is 30.05%, these being held by directors and their families*.

Please click on the link below for a list of Directors & Major Shareholders and the percentage of their holdings.

*Excluding MVM Life Science Partners
Link Last updated:
Directors & Major Shareholders 15th July 2010
Details of any restrictions on the transfer of securities

There are no restrictions on the transfer of securities.
  Last updated:
  29th June 2010
Financial information

Please click on the link below for access to the Company's annual and interim reports.
Link Last updated:
Financial information 29th June 2010
Company announcements

Please click on the link below to access notifications made by the Company in the past 12 months.
Link Last updated:
Company announcements 29th July 2010
Admission document and circulars

There have been no circulars or similar publications within the past 12 months.

Please click on the link below to access the Company's Admission Document dated 28th November 2003.
Link Last updated:
Admission Document 29th June 2010
Advisers

Please click on the link below for details of the Company's Nominated Adviser and other key advisers.
Link Last updated:
Advisers 29th June 2010